Global Patent Index - EP 1218015 A2

EP 1218015 A2 20020703 - PHARMACEUTICAL COMPOSITION OF NATEGLINIDE AND ANOTHER ANTIDIABETIC AGENT

Title (en)

PHARMACEUTICAL COMPOSITION OF NATEGLINIDE AND ANOTHER ANTIDIABETIC AGENT

Title (de)

ZUSAMMENSETZUNG WELCHE NATEGLINIDE AND EINE ANDERE ANTIDIABETISCHE VERBINDUNG ENTHÄLT

Title (fr)

PROCEDE DE TRAITEMENT DE TROUBLES DU METABOLISME

Publication

EP 1218015 A2 20020703 (EN)

Application

EP 00972695 A 20001006

Priority

  • EP 0009816 W 20001006
  • US 41530799 A 19991008
  • US 41530899 A 19991008

Abstract (en)

[origin: WO0126639A2] The invention relates to a combination which comprises nateglinide and (a) an antidiabetic phenylacetic acid derivative or (b) acarbose for simultaneous, separate or sequential use, in particular in the treatment of diseases, especially metabolic disorders; to a method of prevention, delay of progression or treatment of metabolic disorders, more especially diabetes, or a disease or condition associated with diabetes, and to a method of improving the bodily appearance of a warm-blooded animal.

IPC 1-7

A61K 31/70; A61K 31/445; A61K 31/195; A61P 3/00

IPC 8 full level

A61K 31/445 (2006.01); A61K 45/06 (2006.01)

CPC (source: EP)

A61K 31/195 (2013.01); A61K 31/445 (2013.01); A61K 31/702 (2013.01); A61K 31/715 (2013.01); A61K 45/06 (2013.01); A61P 3/00 (2017.12)

C-Set (source: EP)

  1. A61K 45/06 + A61K 31/715 + A61K 31/195
  2. A61K 31/702 + A61K 31/195
  3. A61K 31/445 + A61K 31/195
  4. A61K 31/445 + A61K 2300/00
  5. A61K 31/702 + A61K 2300/00

Citation (search report)

See references of WO 0126639A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0126639 A2 20010419; WO 0126639 A3 20020110; AU 1133901 A 20010423; EP 1218015 A2 20020703

DOCDB simple family (application)

EP 0009816 W 20001006; AU 1133901 A 20001006; EP 00972695 A 20001006